Latest Options News

Pantera Lithium has completed a detailed 3D geological model confirming the potential of its Arkansas lithium brine project and raised over $2 million to fund exploration despite initial drilling setbacks.

Centrex Limited corrects its corporate presentation title to January 2025 and details progress on its Ardmore Phosphate Project Stage 1.5 Expansion, supported by a $10.4 million Entitlement Offer aimed at boosting production capacity and financial stability.

BKI Investment Company Limited has announced a fully franked ordinary dividend of AUD 0.039 per share for the half-year ending December 31, 2024, payable on February 28, 2025. The company’s Dividend Reinvestment Plan remains active, offering shareholders flexibility.

BKI Investment Company Limited posted a decline in net profit and earnings per share for the half-year ending December 31, 2024, yet declared a higher fully franked interim dividend, signaling confidence amid economic headwinds.

Centrex Limited has initiated a $10.4 million Entitlement Offer to fund the critical Stage 1.5 Expansion of its Ardmore Phosphate Project, aiming to boost production capacity to 625ktpa. The company highlights the pivotal role of this capital raise in securing operational continuity amid notable financial and logistical risks.

Murray Cod Australia Limited has announced a 10-for-1 security consolidation affecting all ordinary shares and options, aiming to simplify its capital structure ahead of resumed trading in February 2025.

Traffic Technologies Limited has landed a significant $3 million contract to supply smart LED streetlights to the City of Sydney, with potential extensions pushing the deal’s value to $5 million over nine years.

Energy Transition Minerals Ltd has successfully raised A$9.35 million through a strategic share placement, bolstering its financial position to advance the Kvanefjeld Rare Earths Project in Greenland and attracting new international institutional investors.

Recce Pharmaceuticals has successfully dosed all patients in its Phase II trial of RECCE® 327 topical gel for acute bacterial skin infections, showing encouraging preliminary efficacy and safety data. The company is preparing for pivotal Phase III trials in Australia and Indonesia, targeting a significant global market opportunity.

Carnarvon Energy and its partners have deferred key milestones in the Dorado Phase 1 liquids development, pushing back the Final Investment Decision and FPSO purchase. Despite the delay, the Joint Venture remains confident and plans further exploration drilling in 2026.

Thrive Tribe Technologies has appointed Jade Spooner as CEO to spearhead the rapid commercialisation of its Kumu platform and e-commerce marketplace. Spooner’s proven track record in scaling tech startups positions her to lead 1TT into its next growth phase.

Wellnex Life has negotiated a delayed and reduced-cost payment arrangement for its Pain Away acquisition, aligning with its upcoming London Stock Exchange dual listing plans. The move supports the company’s growth momentum following record revenues from Pain Away.